Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Matsumra, K. Sekizawa, M. Nakayama, A. Naitoh, K. Kadono, K. Kamahara, T. Homma (Tsukuba, Ibaraki, Japan). Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease. Eur Respir J 2001; 16: Suppl. 31, 3247

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Body composition and pulmonary function in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Body composition in heart failure and chronic obstructive pulmonary disease patients Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Circulating obestatin in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Low testosterone in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007 Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Body composition in chronic obstructive pulmonary disease and heart failure Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018